SCHEMBL16374042

SCHEMBL16374042

Nc1ncnc2c1ncn2C1O[C@](CF)(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1F

nearest known ligand 0.70

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ P2RX1 P51575 5/20 0.58
▸ P2RX3 P56373 5/20 0.58
▸ P2RX2 Q9UBL9 3/20 0.58
▸ P2RY1 P47900 7/20 0.57
▸ P2RY2 P41231 5/20 0.57
▸ P2RY11 Q96G91 1/20 0.57
▸ P2RX4 Q99571 4/20 0.56
▸ SRC P12931 1/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ RNASEL Q05823 1/20 0.54
▸ MACROD2 A1Z1Q3 1/20 0.52
▸ SIRT6 Q8N6T7 1/20 0.52
▸ MACROD1 Q9BQ69 1/20 0.52
▸ TRPM2 O94759 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16490112 1.00 P2RX1 (0.58) P2RX1P2RX3P2RX2P2RY1P2RY2
SCHEMBL15070749 1.00 P2RX1 (0.58) P2RX1P2RX3P2RX2P2RY1P2RY2
SCHEMBL16374216 0.93 P2RX3 (0.60) P2RX1P2RX3P2RX2P2RY1P2RY2
SCHEMBL16368319 0.93 P2RX3 (0.60) P2RX1P2RX3P2RX2P2RY1P2RY2
SCHEMBL16490110 0.92 P2RX1 (0.57) P2RX1P2RX3P2RX2P2RY1P2RY2
SCHEMBL16490101 0.92 P2RX1 (0.57) P2RX1P2RX3P2RX2P2RY1P2RY2
SCHEMBL15070750 0.92 P2RX1 (0.57) P2RX1P2RX3P2RX2P2RY1P2RY2
SCHEMBL15070748 0.92 P2RX1 (0.57) P2RX1P2RX3P2RX2P2RY1P2RY2
SCHEMBL20754494 0.92 P2RX3 (0.56) P2RX1P2RX3P2RX2P2RY1P2RY2
SCHEMBL19993680 0.91 P2RX3 (0.57) P2RX1P2RX3P2RX2P2RY1P2RY2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014209979-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF ALIOS BIOPHARMA, INC. (US) 2014-12-31 — — WO disclosed
Send feedback